Molecule Details
InChIKeyVNDWQCSOSCCWIP-UHFFFAOYSA-N
Compound NamePyridone 6
Canonical SMILESCC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)39
Pfam Stratification Cross-Family
Avg pChEMBL7.02
SourceBindingDB;ChEMBL;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB04716
Drug Name2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one
CAS Number457081-03-7
Groups experimental
ATC Codes nan
Descriptionnan

Categories: Heterocyclic Compounds, Fused-Ring Pyridines
Cross-references: BindingDB: 26198 ChEBI: 87103 CHEMBL21156 ChemSpider: 4591874 PDB: IZA PubChem:5494425 PubChem:46505719 ZINC: ZINC000012504479
Target Activities (39)
Target Gene Organism Category Pfam pChEMBL Type Source
O43293 DAPK3 Homo sapiens Human PF00069 9.0 Ki ChEMBL
O60674 JAK2 Homo sapiens Human PF18379 PF18377 PF17887 PF07714 PF21990 9.0 IC50 ChEMBL;BindingDB
P29597 TYK2 Homo sapiens Human PF18379 PF18377 PF17887 PF07714 PF21990 9.0 IC50 ChEMBL;BindingDB
P52333 JAK3 Homo sapiens Human PF18379 PF18377 PF17887 PF07714 PF21990 8.3 IC50 ChEMBL;BindingDB
P23458 JAK1 Homo sapiens Human PF18379 PF18377 PF17887 PF07714 PF21990 7.8 IC50 ChEMBL;BindingDB
P45983 MAPK8 Homo sapiens Human PF00069 7.8 Ki ChEMBL
O15530 PDPK1 Homo sapiens Human PF14593 PF00069 7.7 IC50 BindingDB
P29376 LTK Homo sapiens Human PF12810 PF07714 7.6 Ki ChEMBL
Q5S007 LRRK2 Homo sapiens Human PF23745 PF23744 PF23748 PF16095 PF25497 PF13855 PF00069 PF08477 7.6 Ki ChEMBL
P31749 AKT1 Homo sapiens Human PF00169 PF00069 PF00433 7.5 IC50 BindingDB
Q04912 MST1R Homo sapiens Human PF07714 PF01437 PF01403 PF01833 7.5 Ki ChEMBL
Q96GD4 AURKB Homo sapiens Human PF00069 7.3 Ki ChEMBL
O94806 PRKD3 Homo sapiens Human PF00130 PF00169 PF00069 PF25525 7.1 Ki ChEMBL
P45984 MAPK9 Homo sapiens Human PF00069 7.1 Ki ChEMBL
Q9HAZ1 CLK4 Homo sapiens Human PF00069 7.1 Ki ChEMBL
Q14164 IKBKE Homo sapiens Human PF00069 PF18394 PF18396 7.0 Ki ChEMBL
Q07912 TNK2 Homo sapiens Human PF09027 PF11555 PF07714 PF22931 PF14604 6.9 Ki ChEMBL
Q02750 MAP2K1 Homo sapiens Human PF00069 6.8 IC50 ChEMBL;BindingDB
Q13131 PRKAA1 Homo sapiens Human PF16579 PF21147 PF00069 6.8 Ki ChEMBL
Q9UM73 ALK Homo sapiens Human PF12810 PF00629 PF07714 6.8 Ki ChEMBL
P07949 RET Homo sapiens Human PF00028 PF07714 PF17756 PF17812 PF17813 PF22540 6.7 Ki ChEMBL
Q9UHD2 TBK1 Homo sapiens Human PF00069 PF18394 PF18396 6.7 Ki ChEMBL
P36507 MAP2K2 Homo sapiens Human PF00069 6.6 IC50 ChEMBL
O14920 IKBKB Homo sapiens Human PF18397 PF12179 PF00069 6.5 IC50 ChEMBL;BindingDB
P18505 GABRB1 Homo sapiens Human PF02931 PF02932 6.5 pIC50 TTD_MultiTarget
Q14680 MELK Homo sapiens Human PF02149 PF00069 PF21594 6.5 IC50 ChEMBL;BindingDB
P34947 GRK5 Homo sapiens Human PF00069 PF00615 6.4 Ki ChEMBL
P51812 RPS6KA3 Homo sapiens Human PF00069 PF00433 6.4 Ki ChEMBL
P06241 FYN Homo sapiens Human PF07714 PF00017 PF00018 6.3 IC50 ChEMBL;BindingDB
P17612 PRKACA Homo sapiens Human PF00069 6.3 Ki ChEMBL
Q13464 ROCK1 Homo sapiens Human PF25346 PF00069 PF08912 6.3 Ki ChEMBL
P11309 PIM1 Homo sapiens Human PF00069 6.2 Ki ChEMBL
P35916 FLT4 Homo sapiens Human PF07679 PF13927 PF22971 PF07714 PF21339 PF17988 PF22854 6.2 IC50 ChEMBL;BindingDB
Q04759 PRKCQ Homo sapiens Human PF00130 PF21494 PF00069 PF00433 6.1 Ki ChEMBL
Q05397 PTK2 Homo sapiens Human PF21477 PF00373 PF18038 PF03623 PF07714 6.1 Ki ChEMBL
P21802 FGFR2 Homo sapiens Human PF07679 PF13927 PF07714 6.0 IC50 ChEMBL;BindingDB
Q16620 NTRK2 Homo sapiens Human PF07679 PF13855 PF16920 PF01462 PF07714 6.0 Ki ChEMBL
P11362 FGFR1 Homo sapiens Human PF07679 PF00047 PF07714 Clinical TTD_MultiTarget TTD_MultiTarget
P24941 CDK2 Homo sapiens Human PF00069 Clinical TTD_MultiTarget TTD_MultiTarget
DrugBank Target Actions (5)
Target Gene Target Name Action Type
O43293 DAPK3 Death-associated protein kinase 3 binder targets
P23458 JAK1 Tyrosine-protein kinase JAK1 binder targets
O60674 JAK2 Tyrosine-protein kinase JAK2 inhibitor targets
P29597 TYK2 Non-receptor tyrosine-protein kinase TYK2 inhibitor targets
P52333 JAK3 Tyrosine-protein kinase JAK3 inhibitor targets